<DOC>
	<DOCNO>NCT01352429</DOCNO>
	<brief_summary>This study first establish feasibility study register treatment data adult patient diagnosis intermediate risk prostate cancer present definitive radiation treatment either proton radiotherapy Intensity Modulated Radiation Therapy ( IMRT ) . The investigator propose employ hypofractionated strategy image guide treatment improve cancer control decrease toxicity .</brief_summary>
	<brief_title>Mild Hypofractionation With Proton Therapy Intensity Modulated Radiation Therapy ( IMRT ) Intermediate-Risk Prostate Cancer</brief_title>
	<detailed_description>This study do two phase , first , feasibility study registration study . In first , feasibility establish use primary objective set . The second phase begin early 30 day last patient initial phase complete treatment safety feasibility verify . The secondary objective serve objective second phase study .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Inclusion Criteria Histologically confirm prostate adenocarcinoma within 365 day registration . Clinical stage T1aT2c N0 M0 ( AJCC Criteria 6th Ed ) . For suspicious pelvic lymph node &gt; 1.5cm ( exhibit pelvic image ) , biopsy lymph node suggest . Histological evaluation prostate biopsy assignment Gleason score biopsy material ; Gleason score must range 27 . Biopsy &gt; 6 core strongly recommend . ( The high Gleason Score core report pathology report use determine inclusion . ) PSA value &lt; 20 ng/ml within 90 day prior registration , do either prior prostate biopsy , least 21 day prostate biopsy . Zubrod ( ECOG ) status 01 document within 90 day registration . Androgen deprivation discretion treat radiation oncologist . Subjects must give IRBapproved studyspecific inform consent . Subjects must complete required test within specified time frame . Subjects must least 18 year old . Members race ethnic group eligible trial . Exclusion Criteria Clinical stage T3 great ( AJCC Criteria 6th Ed ) . PSA 20 ng/ml great . Gleason score 8 high . Evidence distant metastasis . ( Determined CT scan , MRI , and/or bone scan prior simulation appointment ; image result UPHS supercede result similar scan outside facility . ) Evidence lymph node involvement . Previous prostate cancer surgery include : prostatectomy , hyperthermia , cryosurgery . Previous pelvic radiation prostate cancer . Active rectal diverticulitis , Crohn 's disease , ulcerative colitis . Prior systemic chemotherapy prostate cancer . History proximal urethral stricture require dilatation .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>adult</keyword>
	<keyword>histologically confirm</keyword>
</DOC>